HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at Northland Capmk decreased their Q3 2026 earnings per share (EPS) estimates for HIVE Blockchain Technologies in a research note issued to investors on Monday, June 9th. Northland Capmk analyst M. Grondahl now forecasts that the company will earn $0.03 per share for the quarter, down from their previous forecast of $0.06. Northland Capmk also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at $0.07 EPS.
Separately, Rosenblatt Securities raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday, March 7th. Five research analysts have rated the stock with a strong buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- ESG Stocks, What Investors Should Know
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- Conference Calls and Individual Investors
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
- How to start investing in penny stocks
- Government Mandate Sends eVTOL Stocks Flying
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
